Epigenetic signatures in cancer: Implications for the control of cancer in the clinic

被引:0
作者
Lima, Sheila C. S. [1 ,2 ]
Hernandez-Vargas, Hector [1 ]
Herceg, Zdenko [1 ]
机构
[1] IARC, Epigenet Grp, F-69372 Lyon, France
[2] Inst Nacl Canc INCA, BR-20231050 Rio De Janeiro, Brazil
关键词
Cancer; diagnosis; DNA methylation; epigenetic signature; histone modification; non-coding RNA; outcome prediction; signature of exposure; HISTONE DEACETYLASE INHIBITORS; HUMAN DNA METHYLTRANSFERASES; COLORECTAL-CANCER; MICROTUBULE INHIBITORS; QUANTITATIVE-ANALYSIS; METHYLATION PROFILES; MICRORNA EXPRESSION; OVARIAN-CANCER; LUNG-CANCER; GENES;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Significant progress in the field of cancer epigenetics has enhanced the understanding of epigenetic mechanisms in cellular processes and in abnormal events involved in tumorigenesis. Many studies have investigated epigenetic alterations in cancer cells and have revealed that epigenetic deregulation is important for the development of malignancy. These studies have also demonstrated that epigenetic changes are present in almost every human cancer, and that different cancers may harbor a specific 'epigenetic signature', which can be used for cancer control. This review focuses on studies that have revealed the existence of specific epigenetic changes related to particular cancer types and associated risk-factor exposures, and how these epigenetic signatures may be exploited in the diagnosis, treatment and prevention of cancer.
引用
收藏
页码:316 / 324
页数:9
相关论文
共 72 条
  • [1] MOUSE DNA METHYLASE - METHYLATION OF NATIVE DNA
    ADAMS, RLP
    MCKAY, EL
    CRAIG, LM
    BURDON, RH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 561 (02) : 345 - 357
  • [2] MicroRNA expression in head and neck cancer associates with alcohol consumption and survival
    Avissar, Michele
    McClean, Michael D.
    Kelsey, Karl T.
    Marsit, Carmen J.
    [J]. CARCINOGENESIS, 2009, 30 (12) : 2059 - 2063
  • [3] Banno K, 2006, ONCOL REP, V16, P1189
  • [4] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [5] DNA methylation patterns and epigenetic memory
    Bird, A
    [J]. GENES & DEVELOPMENT, 2002, 16 (01) : 6 - 21
  • [6] DNA methylation markers and early recurrence in stage I lung cancer
    Brock, Malcolm V.
    Hooker, Craig M.
    Ota-Machida, Emi
    Han, Yu
    Guo, Mingzhou
    Ames, Stephen
    Gloeckner, Sabine
    Piantadosi, Steven
    Gabrielson, Edward
    Pridham, Genevieve
    Pelosky, Kristen
    Belinsky, Steven A.
    Yang, Stephen C.
    Baylin, Stephen B.
    Herman, James G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) : 1118 - 1128
  • [7] The international childhood cancer cohort consortium (I4c)
    Brown, Rebecca C.
    Dwyer, Terence
    Kasten, Carol
    Krotoski, Danuta
    Li, Zhu
    Linet, Martha S.
    Olsen, Jorn
    Scheidt, Peter
    Winn, Deborah M.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2007, 36 (04) : 724 - 730
  • [8] Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
    Brueckner, B
    Boy, RG
    Siedlecki, P
    Musch, T
    Kliem, HC
    Zielenkiewicz, P
    Suhai, S
    Wiessler, M
    Lyko, F
    [J]. CANCER RESEARCH, 2005, 65 (14) : 6305 - 6311
  • [9] Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
    Catto, James W. F.
    Miah, Saiful
    Owen, Helen C.
    Bryant, Helen
    Myers, Katie
    Dudziec, Ewa
    Larre, Stephane
    Milo, Marta
    Rehman, Ishtiaq
    Rosario, Derek J.
    Di Martino, Erica
    Knowles, Margaret A.
    Meuth, Mark
    Harris, Adrian L.
    Hamdy, Freddie C.
    [J]. CANCER RESEARCH, 2009, 69 (21) : 8472 - 8481
  • [10] 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation:: mechanistic studies and their implications for cancer therapy
    Christman, JK
    [J]. ONCOGENE, 2002, 21 (35) : 5483 - 5495